The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 Mutation
Clinical trial NCT06561880 · RECRUITING
Trial details
- NCT number
- NCT06561880
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-08
- Primary completion
- 2026-09-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.